Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Promising cancer treatments were found, but the manufacturer closed.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Adding a second method to PROTACs could improve cancer treatment.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.